Balsm Alofoq Medical Co. (9620.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Balsm Alofoq Medical Co. — annual and quarterly history.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | 11↓40.6% | 18↑396.0% | 4↓35.9% | 6 | |
| Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash & Short-Term Investments | 11↓40.6% | 18↑396.0% | 4↓35.9% | 6 | |
| Net Receivables | 0.97↑175.2% | 0.35↓39.4% | 0.58↑45.9% | 0.40 | |
| Accounts Receivable | 0.70↑104.6% | 0.34↑13.1% | 0.30↑0.9% | 0.30 | |
| Other Receivables | 0.27↑2455.7% | 0.01↓96.2% | 0.28↑183.1% | 0.10 | |
| Inventory | 4↑139.8% | 2↑13.6% | 2↑20.3% | 1 | |
| Prepaid Assets | 0.07↓88.0% | 0.61 | 0.00 | 0.00 | |
| Other Current Assets | 5↑1542.8% | 0.28↑825.8% | 0.03 | 0.00 | |
| Total Current Assets | 21↓2.8% | 21↑265.5% | 6↓21.5% | 7 | |
| Property, Plant & Equipment | 15↑24.6% | 12↓6.1% | 13↑71.2% | 8 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Goodwill & Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 15↑24.6% | 12↓6.1% | 13↑71.2% | 8 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 36↑7.1% | 33↑78.4% | 19↑25.2% | 15 | |
| Liabilities | |||||
| Total Payables | 0.80↑48.6% | 0.54↑22.7% | 0.44↓22.1% | 0.56 | |
| Accounts Payable | 0.25↓7.9% | 0.27↓20.0% | 0.34↓22.7% | 0.44 | |
| Other Payables | 0.55↑107.0% | 0.26↑173.1% | 0.10↓19.7% | 0.12 | |
| Accrued Expenses | 0.61 | 0.00↓100.0% | 0.74↑25.2% | 0.59 | |
| Short-Term Debt | 0.23↓26.3% | 0.31↑31.3% | 0.23↓52.8% | 0.50 | |
| Current Lease Obligations | 0.00↓100.0% | 0.31↑31.3% | 0.23 | 0.00 | |
| Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Revenue | 0.00 | 0.00↓100.0% | 0.01↑87.8% | 0.00 | |
| Other Current Liabilities | 0.37↓50.3% | 0.75↑664.5% | -0.13↓104.9% | 3 | |
| Total Current Liabilities | 2↑22.5% | 2↑7.8% | 2↓65.2% | 4 | |
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Lease Obligations | 1↓14.0% | 1↓11.5% | 2↓20.5% | 2 | |
| Non-Current Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 1↑19.2% | 1↑16.0% | 1↑1.9% | 1 | |
| Total Non-Current Liabilities | 3↑0.9% | 3↓0.9% | 3↓13.2% | 3 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 1↓28.7% | 2↓6.3% | 2↓9.5% | 2 | |
| Total Liabilities | 5↑9.0% | 4↑2.2% | 4↓43.4% | 8 | |
| Equity | |||||
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock | 25↑100.0% | 13↑25.0% | 10↑104.1% | 5 | |
| Retained Earnings | 6↓6.0% | 6↑58.3% | 4↑87.5% | 2 | |
| Additional Paid-In Capital | 0.00↓100.0% | 10 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | 0.00 | 0.00↓100.0% | 0.43↑22.4% | 0.35 | |
| Other Stockholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Stockholders' Equity | 31↑6.8% | 29↑101.0% | 14↑95.4% | 7 | |
| Total Equity | 31↑6.8% | 29↑101.0% | 14↑95.4% | 7 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities & Equity | 36↑7.1% | 33↑78.4% | 19↑25.2% | 15 | |
| Balance Sheet Summary | |||||
| Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Debt | 2↓16.1% | 2↓6.3% | 2↓26.6% | 3 | |
| Net Debt | -9↑43.2% | -16↓838.0% | -2↑43.7% | -3 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.